rapid-diagnostics
(2)
Cytovale
Cytovale is a San Francisco-based medical diagnostics company that built IntelliSep, an FDA-cleared blood test that helps emergency departments identify patients at risk of sepsis in about eight minutes. Instead of hunting for a pathogen, the test reads the immune response by measuring the biomechanical properties of white blood cells using microfluidic deformability cytometry, high-speed imaging and machine learning. Founded on academic research that began in 2007 and incorporated in 2013, the company is applying its rapid host-response platform to one of medicine's most time-sensitive and deadly conditions.
Maternova, Inc.
Maternova is a woman-owned, woman-run social enterprise based in Providence, Rhode Island that curates, evaluates, and distributes evidence-based medical devices and diagnostics for maternal, neonatal, and reproductive health in low- and middle-income countries. Founded in 2009 as the first e-commerce marketplace for global health technologies, it connects inventors and manufacturers who lack distribution with the governments, NGOs, hospitals, and clinicians who need life-saving tools - aggregating small orders to unlock manufacturing runs and accelerate access to innovations that prevent maternal and infant deaths.